Evidence map›Paper›PMID 41982945›Full record

ArticleTranslational pediatrics2026

Risk factors for postoperative recurrence of thyroid cancer patients in children, adolescents, and young adults.

Mengran Tian, Xing Wan, Chuanxiang Hu, Jingtai Zhi, Linfei Hu, Xianhui Ruan, Ming Gao, Jingzhu Zhao, Xiangqian Zheng

Abstract read
In one paragraph

Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mengran Tian *Department of Thyroid and Breast Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China.
Xing Wan *Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Chuanxiang Hu *Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Jingtai ZhiDepartment of Otorhinolaryngology, Head and Neck Surgery, Tianjin First Central Hospital, Institute of Otolaryngology of Tianjin, Key Laboratory of Auditory Speech and Balance Medicine, Key Medical Discipline of Tianjin (Otolaryngology), Quality Control Centre of Otolaryngology, Tianjin, China.
Linfei HuDepartment of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Xianhui RuanDepartment of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Ming GaoDepartment of Thyroid and Breast Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China.
Jingzhu ZhaoDepartment of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Xiangqian ZhengDepartment of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The incidence of pediatric thyroid cancer increases sustainably in the past years. Pediatric thyroid cancer is different from adult thyroid cancer in pathophysiology, clinical characteristics and others, which determines the different treatment methods for pediatric thyroid cancer and adult patients. In order to avoid the overtreatment of younger patients, this study aims to explore the effect of clinically pathological features on postoperative recurrence of thyroid cancer in younger patients. Methods: A total of 234 patients ≤25 years and 311 patients >25 years of age with papillary thyroid carcinoma from Medical University Cancer Institute and Hospital were enrolled in the retrospective study. We retrospectively analyzed thyroid cancer patients, stratified by age (<18, 18-25, >25 years). Clinicopathological features were compared using log-rank tests; multivariable Cox regression identified recurrence predictors, and Kaplan-Meier analyses assessed recurrence-free survival (RFS). Results: Patients aged <18 and 18-25 years showed comparable clinical characteristics (only sex distribution differed, P=0.02), supporting a unified children, adolescents, and young adult (CAYA) cohort (≤25 years). CAYA patients exhibited higher rates of bilateralism, multifocality, papillary thyroid microcarcinoma, extrathyroidal extension, lymphatic metastasis, and recurrence. Lymphatic metastasis [Exp(B) =6.818, P=0.009] and lateral cervical lymph node (LN) dissection [Exp(B) =3.044, P=0.005] were independent recurrence predictors. Lymphatic metastasis (presence, ≥5 nodes, or lateral location) correlated with poorer RFS (P≤0.006). Conclusions: LN metastasis is an important risk factor for postoperative recurrence in CAYA patients, suggesting that preoperative attention should emphasize the assessment of LN metastasis, including the number and area.

Indexed as

lymphatic metastasisPediatric cancerprognosisthyroid cancer

Identifiers

PMID41982945
PMCPMC13071663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.